Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?

To: Cacaito who wrote (9394)	4/5/1999 10:21:00 PM
From: StockDoc	Respond to of 17367

Cacaito, your response is informative to those who haven't seen the disease and need some additional training (and I don't have the opportunity to do that for them). You correctly quote that > " ....Only 5% to 10% of meningococcal disease are meningococcemia (septic shock type) 90% to 95% are meningitis...".< It is also true that "... Menigitic meningococci disease...is an acute ... syndrome. Most of the patients will have the bacteria in the blood...". Meningococcemia, however, is not a syndrome, although there is a syndrome (W-F syndrome) caused by meningococcemia. Meningococcemia is a laboratory finding. Meningococcemia (for those who don't speak Latin, it means "meningococcus bacteria in the blood") can be found in >95% of the meningitis cases. And indeed, only 5 to 10% develop septic shock due to this meningococcemia. Those patients will most likely die (i.e., this is responsible for significant percentage of the mortality). This is exactly what I tried to explain to you in my previous note. Keep up with the good job. Regards, Stockdoc